Literature DB >> 12718444

A comparative study between a brain Na+,K(+)-ATPase inhibitor (endobain E) and ascorbic acid.

G Rodríguez de Lores Arnaiz1, T Herbin, C Peña.   

Abstract

In the search of Na+,K(+)-ATPase modulators, we have reported the isolation by gel filtration and HPLC of a brain fraction, termed endobain E, which highly inhibits Na+,K(+)-ATPase activity. In the present study we compared some properties of endobain E with those of ascorbic acid. Kinetic experiments assaying synaptosomal membrane K(+)-p-nitrophenylphosphatase (K(+)-p-NPPase) activity in the presence of endobain E or ascorbic acid showed that in neither case did enzyme inhibition prove competitive in nature versus K+ or p-NPP concentration. At pH 5.0, endobain E and ascorbic acid maximal UV absorbance was 266 and 258 nm, respectively; alkalinization to pH 14.0 led to absorption drop and shift for endobain E but to absorbance disappearance for ascorbic acid. After cysteine treatment, endobain E absorbance decreased, whereas that of ascorbic acid remained unaltered; iodine treatment led to absorbance drop and shift for endobain E but to absorbance disappearance for ascorbic acid. HPLC analysis of endobain E disclosed the presence of two components: one eluting with retention time and UV spectrum indistinguishable from those of ascorbic acid and a second, as yet unidentified, both exerting Na+,K(+)-ATPase inhibition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12718444     DOI: 10.1023/a:1023227510707

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  40 in total

Review 1.  How many endobains are there?

Authors:  G Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

2.  Vitamin C--effects on the Na+, K+ adenosine triphosphate phosphohydrolase complexes of several tissues.

Authors:  M Frey; B J Pitts; A Askari
Journal:  Biochem Pharmacol       Date:  1973-01-01       Impact factor: 5.858

3.  Inhibition of Mg- and Mg, Na, K-activated adenosine tgriphosphatase activity by L-ascorbic acid and L-cysteine.

Authors:  C Inagaki
Journal:  Jpn J Pharmacol       Date:  1970-03

4.  Dynamic changes in extracellular fluid ascorbic acid monitored by in vivo electrochemistry.

Authors:  B Ghasemzadeh; J Cammack; R N Adams; B Ghasemzedah
Journal:  Brain Res       Date:  1991-04-26       Impact factor: 3.252

5.  Diuretic and natriuretic effect of a brain soluble fraction that inhibits neuronal Na+,K(+)-ATPase.

Authors:  S Nowicki; M A Enero; G Rodriguez de Lores Arnaiz
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

6.  Inhibitory effects of ascorbic acid on dopamine uptake by rat striatal synaptosomes: relationship to lipid peroxidation and oxidation of protein sulfhydryl groups.

Authors:  P Morel; B Fauconneau; G Page; T Mirbeau; F Huguet
Journal:  Neurosci Res       Date:  1998-10       Impact factor: 3.304

7.  An endogenous factor which interacts with synaptosomal membrane Na+, K(+)-ATPase activation by K+.

Authors:  G Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  1993-06       Impact factor: 3.996

8.  Rapid changes in striatal ascorbate in response to tail-pinch monitored by constant potential voltammetry.

Authors:  M G Boutelle; L Svensson; M Fillenz
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

9.  Sodium pump inhibitor in the serum of patients with essential hypertension and its partial purification from hemofiltrate.

Authors:  R Kuske; K Moreth; D Renner; V Wizemann; W Schoner
Journal:  Klin Wochenschr       Date:  1987

10.  Regulation of the NMDA receptor by redox phenomena: inhibitory role of ascorbate.

Authors:  M D Majewska; J A Bell; E D London
Journal:  Brain Res       Date:  1990-12-24       Impact factor: 3.252

View more
  6 in total

1.  The effect of endogenous modulator endobain E on NMDA receptor is interfered by Zn2+ but is independent of modulation by spermidine.

Authors:  A Reinés; S Zárate; C Peña; G Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

2.  Changes in Na+, K+-ATPase activity and alpha 3 subunit expression in CNS after administration of Na+, K+-ATPase inhibitors.

Authors:  María Geraldina Bersier; Clara Peña; Georgina Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2010-11-16       Impact factor: 3.996

3.  The expression of NMDA receptor subunits in cerebral cortex and hippocampus is differentially increased by administration of endobain E, a Na+, K+-ATPase inhibitor.

Authors:  María Geraldina Bersier; Clara Peña; Georgina Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2007-08-08       Impact factor: 3.996

4.  The anticancer drug perillyl alcohol is a Na/K-ATPase inhibitor.

Authors:  Diogo G Garcia; Lidia M F Amorim; Mauro V de Castro Faria; Aline S Freire; Ricardo E Santelli; Clóvis O Da Fonseca; Thereza Quirico-Santos; Patricia Burth
Journal:  Mol Cell Biochem       Date:  2010-08-06       Impact factor: 3.396

5.  Modulation of aspartate release by ascorbic acid and endobain E, an endogenous Na+, K+ -ATPase inhibitor.

Authors:  M G Bersier; V Miksztowicz; C Peña; G Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

6.  Na,K-ATPase activity regulates AMPA receptor turnover through proteasome-mediated proteolysis.

Authors:  Dawei Zhang; Qingming Hou; Min Wang; Amy Lin; Larissa Jarzylo; Allison Navis; Aram Raissi; Fang Liu; Heng-Ye Man
Journal:  J Neurosci       Date:  2009-04-08       Impact factor: 6.167

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.